Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example

References

• Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741.
   PubMed Web of Science ®Google Scholar
• Arksey H, O’Malley L. 2007. Scoping studies: towards a methodological framework. 10.1080/1364557032000119616.
   Google Scholar
• Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored bradford-hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72(3):514–537.
   PubMed Web of Science ®Google Scholar
• Carvaillo JC, Barouki R, Coumoul X, Audouze K. 2019. Linking bisphenol S to adverse outcome pathways using a combined text mining and systems biology approach. Environ Health Perspect. 127(4):47005.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Sherman S, Said Z, Yauk CL, Stainforth R. 2021. A case example of a radiation-relevant adverse outcome pathway to lung cancer. Int J Radiat Biol. 97(1):68–84.
   PubMed Web of Science ®Google Scholar
• de Vries RBM, Angrish M, Browne P, Brozek J, Rooney AA, Wikoff DS, Whaley P, Edwards SW, Morgan RL, Druwe IL, et al. 2021. Applying evidence-based methods to the development and use of adverse outcome pathways. ALTEX - Alternat Anim Exp. 38(2):336–347.
   Web of Science ®Google Scholar
• Elsevier. 2017. Guidance notes for authors of systematic reviews, systematic evidence maps and related manuscript types. Amsterdam: Elsevier.
   Google Scholar
• Gartlehner G, Wagner G, Lux L, Affengruber L, Dobrescu A, Kaminski-Hartenthaler A, Viswanathan M. 2019. Assessing the accuracy of machine-assisted abstract screening with DistillerAI: a user study. Syst Rev. 8(1):277.
   PubMed Web of Science ®Google Scholar
• Gates A, Guitard S, Pillay J, Elliott SA, Dyson MP, Newton AS, Hartling L. 2019. Performance and usability of machine learning for screening in systematic reviews: a comparative evaluation of three tools. Syst Rev. 8(1):163.
   PubMed Web of Science ®Google Scholar
• Jeong J, Garcia-Reyero N, Burgoon L, Perkins E, Park T, Kim C, Roh JY, Choi J. 2019. Development of adverse outcome pathway for PPARγAntagonism leading to pulmonary fibrosis and chemical selection for its validation: toxcast database and a deep learning artificial neural network model-based approach. Chem Res Toxicol. 32(6):1212–1222.
   PubMed Web of Science ®Google Scholar
• Laurier D, Rühm W, Paquet F, Applegate K, Cool D, Clement C, International Commission on Radiological Protection (ICRP). 2021. Areas of research to support the system of radiological protection. Radiat Environ Biophys. 60(4):519–530.
   PubMed Web of Science ®Google Scholar
• Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, et al. 2017. Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 91(11):3477–3505.
   PubMed Web of Science ®Google Scholar
• Miake-Lye IM, Hempel S, Shanman R, Shekelle PG. 2016. What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products. Syst Rev. 5(1):1–21.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, et al. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. 2018. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 18(1):1–7.
   PubMed Web of Science ®Google Scholar
• OECD. 2018. Users’ handbook supplement to the guidance document for developing and assessing adverse outcome pathways. (OECD Series on Adverse Outcome Pathways No. 1). Paris, France: OECD.
   Google Scholar
• [OHAT] Office of Health Assessment and Translation. 2019. Handbook for conducting a literature-based health assessment using OHAT approach for systemic review and evidence integration. Washington (DC): U.S. Department of Health and Human Services.
   Google Scholar
• Patel ZS, Brunstetter TJ, Tarver WJ, Whitmire AM, Zwart SR, Smith SM, Huff JL. 2020. Red risks for a journey to the red planet: the highest priority human health risks for a mission to mars. NPJ Microgravity. 6(1):1–13.
   PubMed Web of Science ®Google Scholar
• Pelch KE, Reade A, Wolffe TAM, Kwiatkowski CF. 2019. PFAS health effects database: protocol for a systematic evidence map. Environ Int. 130:104851.
   PubMed Web of Science ®Google Scholar
• Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. 2015. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 13(3):141–146.
   PubMed Web of Science ®Google Scholar
• Preston RJ, Rühm W, Azzam EI, Boice JD, Bouffler S, Held KD, Little MP, Shore RE, Shuryak I, Weil MM. 2021. Adverse outcome pathways, key events, and radiation risk assessment. Int J Radiat Biol. 97(6):804–814.
   Google Scholar
• Rugard M, Coumoul X, Carvaillo JC, Barouki R, Audouze K. 2020. Deciphering adverse outcome pathway network linked to bisphenol F using text mining and systems toxicology approaches. Toxicol Sci. 173(1):32–40.
   PubMed Web of Science ®Google Scholar
• Svingen T, Villeneuve DL, Knapen D, Panagiotou EM, Draskau MK, Damdimopoulou P, O’Brien JM. 2021. A pragmatic approach to adverse outcome pathway development and evaluation. Toxicol Sci. 184(2):183–190.
   PubMed Web of Science ®Google Scholar
• van der Mierden S, Tsaioun K, Bleich A, Leenaars CHC. 2019. Software tools for literature screening in systematic reviews in biomedical research. ALTEX. https://doi.org/10.14573/altex.1902131
   Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, et al. 2014. Adverse outcome pathway development II: best practices. Toxicol Sci. 142(2):321–330.
   PubMed Web of Science ®Google Scholar
• Wolffe TAM, Whaley P, Halsall C, Rooney AA, Walker VR. 2019. Systematic evidence maps as a novel tool to support evidence-based decision-making in chemicals policy and risk management. Environ Int. 130:104871.
   PubMed Web of Science ®Google Scholar